Cite

HARVARD Citation

    Kalinsky, K. et al. (n.d.). Ipatasertib in Patients with Tumors with AKT Mutations: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Sub-protocol Z1K. European journal of cancer. pp. S8-S9. [Online]. 
  
Back to record